APPLIED GENETIC TECHNOLOGIES CORP Insider Trading for April 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in APPLIED GENETIC TECHNOLOGIES CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in APPLIED GENETIC TECHNOLOGIES CORP for April 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 21 2014 | AGTC | APPLIED GENETIC TE ... | Washer Susan B. | President & CEO | Option Exercise | A | 14.08 | 99,156 | 1,396,116 | 99,156 | |
| Apr 21 2014 | AGTC | APPLIED GENETIC TE ... | Menichella Daniel L | V.P. & Chief Busine ... | Option Exercise | A | 14.08 | 7,567 | 106,543 | 7,567 | |
| Apr 21 2014 | AGTC | APPLIED GENETIC TE ... | Knop David R. | Director, Process D ... | Option Exercise | A | 14.08 | 6,376 | 89,774 | 6,376 | |
| Apr 21 2014 | AGTC | APPLIED GENETIC TE ... | Chulay Jeffrey D. | V.P. & Chief Medica ... | Option Exercise | A | 14.08 | 19,230 | 270,758 | 19,230 | |
| Apr 02 2014 | AGTC | APPLIED GENETIC TE ... | GLAXOSMITHKLINE PLC | 10% Owner | Option Exercise | C | 0.00 | 15,671,969 | 0 | 0 | |
| Apr 02 2014 | AGTC | APPLIED GENETIC TE ... | GLAXOSMITHKLINE PLC | 10% Owner | Option Exercise | C | 0.00 | 32,707,070 | 0 | 0 | |
| Apr 02 2014 | AGTC | APPLIED GENETIC TE ... | GLAXOSMITHKLINE PLC | 10% Owner | Option Exercise | C | 0.00 | 17,625,289 | 0 | 0 | |
| Apr 02 2014 | AGTC | APPLIED GENETIC TE ... | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 12.00 | 103,762 | 1,245,144 | 1,989,598 | 1.9 M to 2 M (+5.50 %) |
| Apr 02 2014 | AGTC | APPLIED GENETIC TE ... | GLAXOSMITHKLINE PLC | 10% Owner | Buy | C | 0.00 | 1,885,836 | 0 | 1,885,836 | 0 to 1.9 M |
| Apr 21 2014 | AGTC | APPLIED GENETIC TE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Option Exercise | A | 14.08 | 2,502 | 35,228 | 2,502 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Wu Samuel | Director | Option Exercise | C | 4.54 | 11,896 | 54,008 | 11,896 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Wu Samuel | Director | Option Exercise | C | 0.13 | 416,361 | 54,002 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Wu Samuel | Director | Option Exercise | C | 0.00 | 5,699,111 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Wu Samuel | Director | Option Exercise | C | 0.00 | 11,893,926 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Wu Samuel | Director | Option Exercise | C | 0.00 | 6,409,436 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Wu Samuel | Director | Option Exercise | C | 0.00 | 11,478,652 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Wu Samuel | Director | Buy | P | 12.00 | 75,735 | 908,820 | 1,452,196 | 1.4 M to 1.5 M (+5.50 %) |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Wu Samuel | Director | Buy | C | 0.00 | 1,376,461 | 0 | 1,376,461 | 0 to 1.4 M |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Rosen James | Director | Option Exercise | C | 4.54 | 8,920 | 40,497 | 8,920 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Rosen James | Director | Option Exercise | C | 0.13 | 312,228 | 40,496 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Rosen James | Director | Option Exercise | C | 0.00 | 4,273,746 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Rosen James | Director | Option Exercise | C | 0.00 | 8,919,218 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Rosen James | Director | Option Exercise | C | 0.00 | 4,806,416 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Rosen James | Director | Option Exercise | C | 0.00 | 10,443,612 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Rosen James | Director | Buy | P | 12.00 | 62,871 | 754,452 | 1,205,537 | 1.1 M to 1.2 M (+5.50 %) |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Rosen James | Director | Buy | C | 0.00 | 1,142,666 | 0 | 1,142,666 | 0 to 1.1 M |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | ORONSKY ARNOLD L | Director | Option Exercise | C | 4.54 | 11,895 | 54,003 | 11,895 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | ORONSKY ARNOLD L | Director | Option Exercise | C | 0.13 | 416,361 | 54,002 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | ORONSKY ARNOLD L | Director | Option Exercise | C | 0.00 | 5,699,111 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | ORONSKY ARNOLD L | Director | Option Exercise | C | 0.00 | 11,893,926 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | ORONSKY ARNOLD L | Director | Option Exercise | C | 0.00 | 6,409,436 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | ORONSKY ARNOLD L | Director | Option Exercise | C | 0.00 | 11,479,011 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | ORONSKY ARNOLD L | Director | Buy | P | 12.00 | 75,736 | 908,832 | 1,452,216 | 1.4 M to 1.5 M (+5.50 %) |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | ORONSKY ARNOLD L | Director | Buy | C | 0.00 | 1,376,480 | 0 | 1,376,480 | 0 to 1.4 M |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 4.54 | 11,896 | 54,008 | 11,896 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 0.13 | 416,361 | 54,002 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 0.00 | 5,699,111 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 0.00 | 11,893,926 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 0.00 | 6,409,436 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 0.00 | 11,478,652 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | MedImmune Ventures, Inc. | 10% Owner | Buy | P | 12.00 | 75,735 | 908,820 | 1,452,196 | 1.4 M to 1.5 M (+5.50 %) |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | MedImmune Ventures, Inc. | 10% Owner | Buy | C | 0.00 | 1,376,461 | 0 | 1,376,461 | 0 to 1.4 M |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Carroll Jill | Director | Option Exercise | C | 0.00 | 15,671,969 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Carroll Jill | Director | Option Exercise | C | 0.00 | 32,707,070 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Carroll Jill | Director | Option Exercise | C | 0.00 | 17,625,289 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Carroll Jill | Director | Buy | P | 12.00 | 103,762 | 1,245,144 | 1,989,598 | 1.9 M to 2 M (+5.50 %) |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Carroll Jill | Director | Buy | C | 0.00 | 1,885,836 | 0 | 1,885,836 | 0 to 1.9 M |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Alta Partners VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 23,507,953 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Alta Partners VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 49,060,606 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Alta Partners VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 26,437,934 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Alta Partners VIII, L.P. | 10% Owner | Buy | P | 12.00 | 155,645 | 1,867,740 | 2,984,400 | 2.8 M to 3 M (+5.50 %) |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Alta Partners VIII, L.P. | 10% Owner | Buy | C | 0.00 | 2,828,755 | 0 | 2,828,755 | 0 to 2.8 M |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | INTERWEST PARTNERS VIII LP | 10% Owner | Option Exercise | C | 4.54 | 11,895 | 54,003 | 11,895 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | INTERWEST PARTNERS VIII LP | 10% Owner | Option Exercise | C | 0.13 | 416,361 | 54,002 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | INTERWEST PARTNERS VIII LP | 10% Owner | Option Exercise | C | 0.00 | 5,699,111 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | INTERWEST PARTNERS VIII LP | 10% Owner | Option Exercise | C | 0.00 | 11,893,926 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | INTERWEST PARTNERS VIII LP | 10% Owner | Option Exercise | C | 0.00 | 6,409,436 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | INTERWEST PARTNERS VIII LP | 10% Owner | Option Exercise | C | 0.00 | 11,479,011 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | INTERWEST PARTNERS VIII LP | 10% Owner | Buy | P | 12.00 | 75,376 | 904,512 | 1,452,216 | 1.4 M to 1.5 M (+5.47 %) |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | INTERWEST PARTNERS VIII LP | 10% Owner | Buy | C | 0.00 | 1,376,480 | 0 | 1,376,480 | 0 to 1.4 M |